your market intelligence analyst
Search Results
215 results
Your search is now limited to «Sanofi» expert search. 07/22/2019 08:26
According to a newly published report by, “Worldwide TB Vaccines Market: Information About Key Drivers, Restraints, And Opportunities 2019-2029“. The prime objective of the report is to deliver a Ten-year (2019-2029) market forecast. The latest study focusing on tb vaccines market with topmost companies, to determine, define and analyses the sales size, value, market share, market competition landscape, and recent development. It helps to decide a corporate, product, marketing strategy…
More from
ENDPOINTS 07/19/2019 09:48
In January, MyoKardia disclosed that Sanofi was walking away from their heart drug partnership forged in 2014.
More from ENDPOINTS:
GlobeNewswire 07/18/2019 08:30
The companies discontinued that agreement in conjunction with the end of the Research term of the collaboration in December 2018 and the collaboration agreement with Sanofi concluded in its entirety on April 1, 2019.
More from GlobeNewswire:
Business Insider 07/16/2019 16:06
Read more: Pharma giants like Novartis and Sanofi are betting that the future of healthcare looks more like an app or sensor than a prescription So in addition to selling traditional medications like insulin for individuals with diabetes, Sanofi is now also investing in digital offerings ...
FiercePharmaManufacturing 07/12/2019 10:05
A German court ruled that Praluent steps on an Amgen patent, hitting partners Sanofi and Regeneron with an injunction.
More from FiercePharmaManufacturing:
FierceBiotech 07/11/2019 09:04
Elsewhere, the FDA accepted a filing for approval of Sanofi's Darzalex rival.
More from FierceBiotech:
Business Wire 07/11/2019 07:00
Under the terms of the collaboration, Schrödinger provides advanced molecular simulation and computational design expertise to Sanofi across multiple stages of drug discovery, from target analysis and lead optimization to identification of a development candidate.
More from Business Wire:
FDA accepts to review Sanofi’s multiple myeloma candidate isatuximab.
More from Pharmaceutical Business Review:
PMLiVE 07/10/2019 17:47
Johnson & Johnson’s multiple myeloma drug Darzalex has had the anti-CD38 category to itself since 2015, but could face competition from Sanofi’s isatuximab next year.
More from PMLiVE:
MedCity News 07/10/2019 15:05
Sanofi’s filing is based on results of the Phase III ICARIA-MM study, which compared isatuximab combined with Celgene’s Pomalyst (pomalidomide) and dexamethasone against Pomalyst and dexamethasone alone.
More from MedCity News:
Benzinga 07/10/2019 07:17
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks. (Biotech stocks hitting 52-week highs on July 9). Apellis Pharmaceuticals Inc (NASDAQ: ). Athenex Inc (NASDAQ: ). Eidos Therapeutics Inc (NASDAQ: ). Enlivex Therapeutics Ltd (NASDAQ: ). EXACT Sciences Corporation (NASDAQ: ). Principia Biopharma Inc (NASDAQ: ). Down In The Dumps. (Biotech stocks hitting 52-week lows on July 9). Aerpio Pharmaceuticals Inc (NASDAQ: ). Five Prime Therapeutics Inc (NASDAQ: ). Heat Biologics Inc (NASDAQ: ). Ideaya Biosciences Inc (NASDAQ: ). IMMUTEP LTD/S ADR (NASDAQ: ) (raised $7 million through an equity offering). Immunomedics, Inc. (NASDAQ: ). Invivo Therapeutics Holdings Corp (NASDAQ: ). Jaguar Health Inc (NASDAQ: ). OncoSec M.
More from Benzinga:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications